QUCY Stock Summary and Trading Ideas (Mainz Biomed N.V. - | NASDAQ:QUCY)

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

What symbol and exchange does Mainz Biomed N.V. - shares trade?

Mainz Biomed N.V. - trades on the NASDAQ stock market under the symbol QUCY.

What is Mainz Biomed N.V. - stock price doing today?

As of April 16, 2026, QUCY stock price declined to $0.51 with 188,503 million shares trading.

How much is Mainz Biomed N.V. - worth?

QUCY has a market cap of $6.38 million. This is considered a Sub-Micro Cap stock.

How much money does Mainz Biomed N.V. - make?

Last quarter Mainz Biomed N.V. - reported $537,080 in Revenue and -$2.70 earnings per share. This fell short of revenue expectation by $-419,920 and exceeded earnings estimates by $.16.

What are the support and resistance levels for Mainz Biomed N.V. - (QUCY)?

QUCY support price is $.50 and resistance is $.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QUCY shares will trade within this expected range on the day.